New Key Statistics Module, Z-Score and F-Score
NAS:MREO Key Ratios
Market Cap $ M | 623.10 |
Enterprise Value $ M | 547.99 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 7.94 |
Price/Sales | 53.59 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 10.00 |
EPS (TTM) $ | -0.22 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -26.65 |
EV-to-EBITDA | -27.35 |
PEG | -- |
Shares Outstanding M | 153.85 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 6.07 |
Current Ratio | 6.07 |
ROA % (ttm) | -26.48 |
ROE % (ttm) | -34.64 |
ROIC % (ttm) | -124.28 |
Dividend Yield % | -- |
Altman Z-Score | 15.52 |
MREO Number of Guru Trades
MREO Volume of Guru Trades
Gurus Latest Trades with NAS:MREO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:MREO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Mereo BioPharma Group PLC Insider Transactions
No Available Data
News about NAS:MREO
Total 0- 1